Translate this page into:
Male breast cancer: A retrospective review of clinical profile from a tertiary cancer care center of India
*Corresponding author: Dr. Dharma Ram. drdharmapoonia@gmail.com
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
Aim: Present study was done with an aim to analyse the clinicopathological and survival characteristics of male breast cancer patients. Methods: We did a retrospective review of our database and analysed total 27 patients who presented to breast oncology unit of Rajiv Gandhi cancer centre and research institute from January 2010 to April 2016. Results: Most common stage at presentation in our study was in stage II. The median follow up was 32.75 months. The actuarial 5-year survival was 92.30% and DFS was 76.30%. Only hormone receptor status was found as a significant prognostic variable among the prognostic factors studied for disease free survival. Conclusions: Carcinoma breast in male is a relatively rare disease and management principles are translated from our understanding of breast cancer in women. A relatively early stage at presentation is a contrasting finding of our series which may be responsible for a significantly better actuarial 5 year survival rates.
Keywords
References
- Anon. Available at: Fact Sheets by Cancer; 2017. Available from: http://www.globocan.iarc. fr/Pages/fact_sheets_cancer.aspx. [Last accessed on 2017 Apr 20].
- Anon. Available at: What are the Key Statistics about Breast Cancer in Men? 2017. Available from: http://www.cancer.org/cancer/breastcancerinmen/ detailedguide/breast-cancer-in-men-key-statistics. [Last accessed on 2017 Apr 20].
- Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006;367:595-604.
- Shukla NK, Seenu V, Goel AK, Raina V, Rath GK, Singh R, et al. Male breast cancer: A retrospective study from a regional cancer center in Northern India. J Surg Oncol 1996;61:143-8.
- Mitra D, Manna A, Sikdar SK, Sur PK. Clinicopathological study and its prognostic implication in male breast carcinoma. J Indian Med Assoc 2007;105:681-3, 686.
- Chikaraddi SB, Krishnappa R, Deshmane V. Male breast cancer in Indian patients: Is it the same? Indian J Cancer 2012;49:272-6.
- Shah P, Robbani I, Shah O. Clinicopathological study of male breast carcinoma: 24 years of experience. Ann Saudi Med 2009;29:288-93.
- Rai B, Ghoshal S, Sharma SC. Breast cancer in males: A PGIMER experience. J Cancer Res Ther 2005;1:31-3.
- Mukherjee A, Saha A, Chattopadhyay S, Sur P. Clinical trends and outcomes of male breast cancer: Experience of a tertiary oncology centre in India. Int J Cancer Ther Oncol 2014;2:20-35.
- Sundriyal D, Kotwal S, Dawar R, Parthasarathy KM. Male breast cancer in India: Series from a cancer research centre. Indian J Surg Oncol 2015;6:384-6.
- Gogia A, Raina V, Deo SV, Shukla NK, Mohanti BK. Male breast cancer: A single institute experience. Indian J Cancer 2015;52:526-9.
- de Perrot M, Deléaval J, Robert J, Spiliopoulos A. Thirty-year experience of surgery for breast carcinoma in men. Eur J Surg 2000;166:929-31.
- Tawil AN, Boulos FI, Chakhachiro ZI, Otrock ZK, Kandaharian L, El Saghir NS, et al. Clinicopathologic and immunohistochemical characteristics of male breast cancer: A single center experience. Breast J 2012;18:65-8.